Cardiac phenotype in ATP1A3-related syndromes: A multicentre cohort study

Simona Balestrini, Mohamad A Mikati, Reyes Alvarez Garcia-Roves, Michael Carboni, Arsen S Hunanyan, Bassil Kherallah, Melissa McLean, Lyndsey Prange, Elisa De Grandis, Alessandra Gagliardi, Livia Pisciotta, Michela Stagnaro, Edvige Veneselli, Jaume Campistol, Carmen Fons, Leticia Pias-Peleteiro, Allison Brashear, Charlotte Miller, Raquel Samoes, Vesna BrankovicQuasar S Padiath, Ana Potic, Jacek Pilch, Katharina Vezyroglou, Ann M E Bye, Andrew M Davis, Monique M Ryan, Christopher Semsarian, Georgina Hollingsworth, Ingrid E Scheffer, Tiziana Granata, Nardo Nardocci, Francesca Ragona, Alexis Arzimanoglou, Eleni Panagiotakaki, Ines Carrilho, Claudio Zucca, Jan Novy, Karolina Dzieżyc, Marek Parowicz, Maria Mazurkiewicz-Bełdzińska, Sarah Weckhuysen, Roser Pons, Sergiu Groppa, Daniel S Sinden, Geoffrey S Pitt, Andrew Tinker, Michael Ashworth, Zuzanna Michalak, Maria Thom, J Helen Cross, Rosaria Vavassori, Juan P Kaski, Sanjay M Sisodiya

Research output: Contribution to journalArticlepeer-review


OBJECTIVE: To define the risks and consequences of cardiac abnormalities in ATP1A3-related syndromes.

METHODS: Patients meeting clinical diagnostic criteria for Rapid-onset Dystonia-Parkinsonism (RDP), Alternating Hemiplegia of Childhood (AHC), and Cerebellar ataxia, Areflexia, Pes cavus, Optic atrophy, and Sensorineural hearing loss (CAPOS), with ATP1A3 genetic analysis, and had at least one cardiac assessment, were included. We evaluated the cardiac phenotype in an Atp1a3 knock-in mouse (Mashl+/-) to determine the sequence of events in seizure-related cardiac death.

RESULTS: 98 AHC, nine RDP, and three CAPOS patients (63 females, mean age 17 years) were included. Resting EKG abnormalities were found in 52/87 (60%) AHC, 2/3 (67%) CAPOS, and 6/9 (67%) RDP patients. Serial EKGs showed dynamic changes in 10/18 AHC patients. The first Holter EKG was abnormal in 24/65 (37%) AHC and RDP cases, with either repolarization or conduction abnormalities. Echocardiography was normal. Cardiac intervention was required in 3/98 (∼3%) AHC patients. In the mouse model, resting EKGs showed intra-cardiac conduction delay; during induced seizures, heart block or complete sinus arrest led to death.

CONCLUSIONS: We found increased prevalence of EKG dynamic abnormalities in all ATP1A3-related syndromes, with a risk of life-threatening cardiac rhythm abnormalities equivalent to that in established cardiac channelopathies (∼3%). Sudden cardiac death due to conduction abnormality emerged as a seizure-related outcome in murine Atp1a3-related disease. ATP1A3-related syndromes are cardiac diseases as well as neurological diseases. We provide guidance to identify patients potentially at higher risk of sudden cardiac death who may benefit from insertion of a pacemaker or implantable cardioverter-defibrillator.

Original languageEnglish
Pages (from-to)e2866-e2879
Number of pages15
Issue number21
Publication statusPublished - 2020


Dive into the research topics of 'Cardiac phenotype in ATP1A3-related syndromes: A multicentre cohort study'. Together they form a unique fingerprint.

Cite this